Denervation and NKI receptor block modulate stimulated CGRP and PGE2 release from rat skin

NeuroReport

Volumn 11, Issue 2, 2000, Pages 283-286

  Sauer, Susanne K ^a   Averbeck, Beate ^a   Reeh, Peter W ^a  

^a UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

Author keywords

Bradykinin; Inflammation; Neurokinin I receptor; Neuropeptides; Nociception; SR 140333

Indexed keywords

BRADYKININ; CALCITONIN GENE RELATED PEPTIDE; NEUROKININ 1 RECEPTOR; PROSTAGLANDIN E2;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; AUTONOMIC DENERVATION; ENZYME IMMUNOASSAY; IN VITRO STUDY; INFLAMMATION; NERVE ENDING; NOCICEPTION; NONHUMAN; PRIORITY JOURNAL; PROSTAGLANDIN SYNTHESIS; RAT; RECEPTOR BLOCKING;

EID: 0033979458     PISSN: 09594965     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001756-200002070-00012     Document Type: Article

References (25)

1. 1. Mizumura K. Pain Rev 5, 59-82 (1998).
2. 2. Levine JD, Taiwo YO, Collins SD et al. Nature 323, 158-160 (1986).
3. 3. Jänig W, Levine JD and Michaelis M. Prog Brain Res 113, 161 -184 (1996).
4. 4. Koltzenburg M, Kress M and Reeh PW. Neurosci 46, 465-473 (1992).
5. 5. Donnerer J, Amann R and Lembeck F. Neurosci 45, 761-765 (1991).
6. 6. Meyer RA, Davis KD, Raja SN et al. Pain 51, 323-327 (1992).
7. 7. Cambridge H and Brain SD. Br J Pharmacol 115, 641-647 (1995).
8. 8. Willis AL and Smith DL. Metabolism of arachidonic acid: an overview. In: Cunningham FM, ed. The Handbook of Immunopharmacology: Lipid Mediators. London, San Diego: Academic Press, 1994: 2-32.
9. 9. Averbeck B and Reeh PW. Pflügers Arch 433, 76 (1997).
10. 10. Sauer SK, Schäfer D, Kress M et al. Life Sci 62, 2045-2055 (1998).
11. 11. Kress M, Guthmann C, Averbeck B et al. Neuroscience 89,303-310 (1999).
12. 12. Kähler CM, Herold M and Wiedermann CJ. J Cell Physiol 156, 579-587 (1993).
13. 13. Ebersberger A, Averbeck B, Messlinger K et al. Neuroscience 89, 901-907 (1999).
14. 14. Emonds-Alt X, Doutremepuich JD, Heaulme M et al. Eur J Pharmacol 250, 403-413 (1993).
15. 15. Brune K, Reinke M, Lanz R et al. FEBS Lett 186, 46-50 (1985).
16. 16. Hall JM. Gen Pharmacol 28, 1-6 (1997).
17. 17. Beiche F, Klein T, Nusing R et al. J Neuroimmunol 89, 26-34 (1998).
18. 18. Malcangio M and Bowery NG. Br J Pharmacol 113, 635-641 (1994).
19. 19. Levine JD, Fields HL and Basbaum AI. J Neurosci 13, 2273-2286 (1993).
20. 20. le Greves P, Nyberg F, Hökfelt T et al. Reg Pept 25, 277-286 (1989).
21. 21. Brain SD and Williams TJ. Nature 335, 73-75 (1988).
22. 22. Le Greves P, Nyberg F, Terenius L et al. Eur J Pharmacol 115, 309-311 (1999).
23. 23. Segond von Blanchet G, Petersen M and Schaible H-G. Neuroscience 90, 677-684 (1999).
24. 24. Donnerer J, Schuligoi R and Stein C. Neuroscience 49, 693-698 (1992).
25. 25. Ahmed M, Bjurholm A, Schultzberg M et al. Neurosci 38, 699-709 (1995).